Connection

ROBERT F GAGEL to Adrenal Gland Neoplasms

This is a "connection" page, showing publications ROBERT F GAGEL has written about Adrenal Gland Neoplasms.
Connection Strength

0.935
  1. Pheochromocytoma and medullary thyroid carcinoma: a new genotype-phenotype correlation of the RET protooncogene 891 germline mutation. J Clin Endocrinol Metab. 2004 Aug; 89(8):4142-5.
    View in: PubMed
    Score: 0.177
  2. Recontacting Patients with Updated Genetic Testing Recommendations for Medullary Thyroid Carcinoma and Pheochromocytoma or Paraganglioma. Ann Surg Oncol. 2018 May; 25(5):1395-1402.
    View in: PubMed
    Score: 0.113
  3. Evaluation of the incidental adrenal mass. Am J Med. 1997 Sep; 103(3):249-50.
    View in: PubMed
    Score: 0.110
  4. The characterization of pheochromocytoma and its impact on overall survival in multiple endocrine neoplasia type 2. J Clin Endocrinol Metab. 2013 Nov; 98(11):E1813-9.
    View in: PubMed
    Score: 0.083
  5. The evolving field of tyrosine kinase inhibitors in the treatment of endocrine tumors. Endocr Rev. 2010 Aug; 31(4):578-99.
    View in: PubMed
    Score: 0.067
  6. The clinical outcome of prospective screening for multiple endocrine neoplasia type 2a. An 18-year experience. N Engl J Med. 1988 Feb 25; 318(8):478-84.
    View in: PubMed
    Score: 0.057
  7. Impact of prospective screening for multiple endocrine neoplasia type 2. Henry Ford Hosp Med J. 1987; 35(2-3):94-8.
    View in: PubMed
    Score: 0.052
  8. Surgical management of hereditary pheochromocytoma. J Am Coll Surg. 2004 Apr; 198(4):525-34; discussion 534-5.
    View in: PubMed
    Score: 0.043
  9. Evaluation and surgical resection of adrenal masses in patients with a history of extra-adrenal malignancy. Surgery. 2001 Dec; 130(6):1060-7.
    View in: PubMed
    Score: 0.037
  10. Limitations of size as a criterion in the evaluation of adrenal tumors. Surgery. 2000 Dec; 128(6):973-82;discussion 982-3.
    View in: PubMed
    Score: 0.034
  11. Duplication of the mutant RET allele in trisomy 10 or loss of the wild-type allele in multiple endocrine neoplasia type 2-associated pheochromocytomas. Cancer Res. 2000 Nov 15; 60(22):6223-6.
    View in: PubMed
    Score: 0.034
  12. Screening for MEN1 mutations in patients with atypical endocrine neoplasia. Surgery. 1999 Dec; 126(6):1097-103; discussion 1103-4.
    View in: PubMed
    Score: 0.032
  13. Unknown primary cancer presenting as an adrenal mass: frequency and implications for diagnostic evaluation of adrenal incidentalomas. Surgery. 1998 Dec; 124(6):1115-22.
    View in: PubMed
    Score: 0.030
  14. Cortical-sparing adrenalectomy for patients with bilateral pheochromocytoma. Surgery. 1996 Dec; 120(6):1064-70; discussion 1070-1.
    View in: PubMed
    Score: 0.026
  15. Changing concepts in the management of hereditary and sporadic medullary thyroid carcinoma. Endocrinol Metab Clin North Am. 1990 Sep; 19(3):613-35.
    View in: PubMed
    Score: 0.017
  16. Multiple endocrine neoplasia type 2a associated with cutaneous lichen amyloidosis. Ann Intern Med. 1989 Nov 15; 111(10):802-6.
    View in: PubMed
    Score: 0.016
  17. The clinical and screening age-at-onset distribution for the MEN-2 syndrome. Am J Hum Genet. 1989 Feb; 44(2):208-15.
    View in: PubMed
    Score: 0.004
  18. Natural history of familial medullary thyroid carcinoma: effect of a program for early diagnosis. N Engl J Med. 1978 Nov 02; 299(18):980-5.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.